mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
WAY-362450 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.3 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.063 |
0.3 |